News About: Pharm. Industry
Uncertainty shrouds domestic pharmaceutical sector
Korea’s innovative drug firms are likely to suffer further setbacks as joint probe team raided the headquarters of the nation’s leading pharmaceutical company Daewoong Pharmaceutical Thursday to probe an allegation th...
KPMA mulls public hearing over cash reward system
The Korea Pharmaceutical Manufacturers Association (KPMA) is considering proposing a public hearing to the Ministry of Health and Welfare (MOHW) over the contentious cash reward system for doctors and pharmacists, acc...
Crystal Genomics to commence dosing in Phase 3 studies of CG100649 for osteoporosis
Crystal Genomics (CG) said Thursday it will commence dosing in Phase 3 clinical trials of CG100649, a next-generation non-steroidal anti-inflammatory drug (NSAID) for the treatment of osteoporosis (OA).
The current...
Tension escalates among health ministry, drugmakers and wholesalers
The Ministry of Health and Welfare is expected to make its final decision shortly on whether the contentious cash reward system for doctors and pharmacists exists or not from next January.
So far, local drug firms ...
Ildong, CoLucid sign distribution and supply agreement for lasmiditan, a novel agent for acute migra
Ildong Pharmaceutical said Wednesday that it has signed distribution and supply agreement with the U.S.-based CoLucid Pharmaceuticals for lasmiditan in Southeast Asia as well as Korea.
Under the agreement, CoLucid ...
Dong-A ST’s licensing-out treatment is under new drug application in the U.S.
Cubist Pharmaceuticals, Inc., a new U.S. partner of Dong-A ST, said on Tuesday that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of its investigational anti...
KDDF focusing on linking partnerships between Korean drug firms and multinational companies
Korea has emerged as a hub for world-class research in Asia, thanks to significant government and private sector support over the past two decades.
To further strengthen its leadership on the international stage, t...
Samsung BioLogics forms long-term partnership with Roche in Korea
Samsung BioLogics on Tuesday said that it has entered into a long term strategic manufacturing agreement with F. Hoffmann-La Roche over the production of biopharmaceutical products.
Under the agreement, Samsung Bio...
CJ’s incrementally modified drug to be launched from next January
CJ Pharma has recently unveiled its plan to launch its incrementally modified drug (IMD) Vogmet from next January.
Last June, the Ministry of Food and Drug Safety (MFDS) approved another combination of metformin pl...
Hanmi to roll out new combination NSAID drug
Hanmi Pharmaceutical Co. said Wednesday that it will launch a combination drug Naxozol, which combines the two most commonly prescribed naproxen, a non-steroidal anti-inflammatory agent (NSAID) and esomeprazole stront...
